September 24, 2025
The 48th annual scientific symposium featured lively talks on cancer discovery and application, marked the kickoff of UNC Lineberger’s 50th anniversary as an NCI-designated cancer center, and celebrated Shelley Earp, MD, for his leadership at UNC and nationally.
March 3, 2023
Albert Baldwin, PhD, is the 2022 recipient of the Hyman L. Battle Distinguished Cancer Research Award. The award recognizes exceptional cancer research at UNC-Chapel Hill.
October 3, 2022
The National Cancer Institute has awarded the UNC Lineberger Pancreatic Cancer Center of Excellence a five-year, $10.9 million Pancreatic Cancer Specialized Program of Research Excellence (SPORE) grant.
May 6, 2022
UNC Lineberger’s 45th annual Scientific Symposium featured talks on the latest research on pancreatic cancer, tumor microenvironments, metastatic disease and immunotherapy.
August 10, 2021
The Carolina Cancer Association is an organization for students studying biology to learn more about cancer and gain access to UNC Lineberger’s resources.
July 19, 2018
In a study published in the journal Science, researchers led by UNC Lineberger's Qing Zhang, PhD, suggest that ZHX2 is a potential new therapeutic target for clear cell renal cell carcinoma, which is the most common type of kidney cancer.
